Scottish Enterprise
£47.5 million fund for UK life sciences
May 29, 2014Research and Development, Sales and Marketing European Investment Fund, Scottish Enterprise, Strathclyde Pension Fund, UK, epidarex, life sciences, lilly
A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
